To assess the benefits and harms of immune checkpoint inhibitors versus placebo, no treatment, or other systemic or locoregional therapies for people with unresectable hepatocellular carcinoma.
This is a protocol.
Cochrane
Trusted evidence.
Informed decisions.
Better health.